1291094-65-9

Basic information

• Product Name: 6-[(2-bromo-5-iodophenyl)methyl]-2,3-dihydro-1,4-benzodioxin
• Synonyms: 6-[(2-bromo-5-iodophenyl)methyl]-2,3-dihydro-1,4-benzodioxin
• CAS NO: 1291094-65-9
• Molecular Weight: 431.068
• Mol File: 1291094-65-9.mol
• Article Data: 6

Chemical Properties

• CAS DataBase Reference: 6-[(2-bromo-5-iodophenyl)methyl]-2,3-dihydro-1,4-benzodioxin(CAS DataBase Reference)
• NIST Chemistry Reference: 6-[(2-bromo-5-iodophenyl)methyl]-2,3-dihydro-1,4-benzodioxin(1291094-65-9)
• EPA Substance Registry System: 6-[(2-bromo-5-iodophenyl)methyl]-2,3-dihydro-1,4-benzodioxin(1291094-65-9)

Safety Data

• Hazardous Substances Data: 1291094-65-9(Hazardous Substances Data)

Upstream product

• 25252-00-0 2-bromo-5-iodobenzoic acid 
• 1261570-98-2 2-bromo-5-iodobenzoyl chloride 
• 1291094-64-8 (2-bromo-5-iodophenyl)-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)methanone 

Downstream Products

• 1291094-66-0 (3R,4S,5S,6R)-2-(4-bromo-3-((2,3-dihydrobenzo[b][1,4]dioxin-6-yl)meth yl)phenyl)-6-(hydroxymethyl)-2-methoxytetrahydro-2H-pyran-3,4,5-triol 

Relevant articles and documents

Glucopyranosyl derivative and its use in medicine (by machine translation)

The invention relates to a as sodium-dependent glucose transporter (SGLTs) inhibitors of the glucopyranosyl derivative, containing the pharmaceutical composition and its use in medicine, in particular of formula (I) indicated by the glucopyranosyl derivative or its pharmaceutically acceptable salt or all of its stereoisomers, or containing the pharmaceutical composition and said derivative and pharmaceutical composition for the preparation of a medicine for treating diabetes and diabetes related diseases of the use. (by machine translation)

GLYCOSIDE DERIVATIVES AND USES THEREOF

The present invention provides a compound of formula I; a method for manufacturing the compounds of the invention, and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical compo

GLYCOSIDE DERIVATIVES AND USES THEREOF

This invention relates to compounds represented by formula (I): wherein the variables are defined as herein above, which are useful for treating diseases and conditions mediated by the sodium D-glucose co-transporter (SGLT), e.g. diabetes. The invention also provides methods of treating such diseases and conditions, and compositions etc. for their treatment